Volume : 10, Issue : 05, May – 2023



Authors :

Hadia Huma, Niranjan Panda*, Vurathi Sreenivasulu, L.Rajesh Patro

Abstract :

Fexofenadine is prescribed for the treatment of allergy symptoms in males. The liver plays a crucial role in fexofenadine’s metabolism. Orodispersible tablets, which are not metabolised in the stomach, were a good choice of dosage form to counteract these limitations. With the goal of achieving rapid disintegration when held beneath the tongue and facilitating direct absorption of the active ingredient by the oral mucosa, the present study sought to design and develop a Fexofenadine Orodispersible Tablet using Croscarmellose Sodium, Cross povidone, and Sodium starch Glycolate as superdisintegrants. Fexofenadine Orodispersible granules were prepared using a wet granulation process, and evaluation findings indicated that all precompression parameters fulfilled the acceptance criteria, indicating that the granules had outstanding flow qualities. A variety of post-compression characterizations of tablets were performed and the results met the requirements of the pharmacopoeia. Different formulations were tested for in vitro release using a USP II paddle type dissolution equipment. Both a first order kinetic model and a zero-order kinetic model were tested in vitro for release kinetics. Compatibility between the medication and excipients was confirmed by FTIR analysis. following conducting DSC investigations to determine the drug and excipient thermal stabilities, it was determined that both were thermally stable following the aforementioned formulations. The optimized formulation was confirmed to be stable over an adequate time period in accelerated stability testing.
Key Words: Orodispersible, Fexofenadine, Croscarmellose Sodium, crosspovidone, Sodium starch glycolate

Cite This Article:

Please cite this article in press Niranjan Panda et al, Formulation Development And Evaluation Of Orodispersible Tablets Of Fexofenadine By Using Combinations Of Superdisintegrants., Indo Am. J. P. Sci, 2023; 10 (05).

Number of Downloads : 10


1. Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm 2004; 30(5): 525-534.
2. Sreenivas SA, Dandagi PM, Gadad AP, Godbloe AM, Hiremath SP, Mastiholimath VS. Orodispersible tablets: New-fangled drug delivery systems – A review. Indian J Pharm Educ Res 2005; 39(4):177-81.
3. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 1998; 50(4): 375-82.
4. Bradoo R, Shahani S, Deewan B, Sudarshan S. Fast dissolving drug delivery system. J Am Med Assoc India 2001;4(10): 27-31.
5. M. Akbar, N. Panda, AV Reddy, “Formulation and Evaluation of Doxofylline Sublingual Tablets Using Sodium Starch Glycolate and Crosscarmellose Sodium as Superdisintegrant” Int. J. of Pharm. Res. & All. Sci. 2015; 4(2):90-100.
6. Niranjan Panda, Afshan Sultana, A Venkateswar Reddy, G. V. Subba Reddy, M.S.Ansari: Formulation Design and Study the effect of Polyplasdone-XL and AC-Di-Sol on Release Profile of Doxofylline Immediate Release Tablets. Int. J. Pharm. Sci. Rev. Res., 32(2), 2015: 67-76.
7. Leon Lachmann, Herbert A, Liberman, Joseph L.Kaing, The theory and practice of Industrial Pharmacy:293-303.
8. Aulton`s Pharmaceutics, The design & manufacture of medicines, Biopharmaceutics and pharmacokinetics, A Treatise, second edition, Valabh Prakashan, 315-84.
9. Shirwaikar R., Shirwaikar A., Prabu L., Mahalaxmi R., Rajendran K., Kumar C. Studies of superdisintegrant properties of seed mucilage of Ocimum gratissimum. Indian Journal of Pharmaceutical sciences. 2007; 69(6): 753-758.
10. Palkhede M., Amrutkar S., Erande K.. Formulation, optimization and evaluation of fast disintegrating tablet of mebeverine HCl. Int J Pharm Pharm Sci. 2012; 4(4):121-125.
11. Parakh SR, Gothoskar AV (2003). A review of mouth dissolving tablet technologies. Pharm Tech 27: 92-98.
12. Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: A Review. Indian Drugs 2004; 41 (4): 187-193.
13. Tanmoy G, Amitava G and Devi P: A review on new generation orodispersible tablet and its future prospective. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3: 1-7.
14. Hirani JJ, Rathod DA and Vadalia KR: Orally Disintegrating Tablets: A Review. Tropical Journal of Pharmaceutical Research 2008; 8(2): 161-172.
15. Arora P, Arora VS: Orodispersible tablets: A comprehensive review. International Journal of Research and Development in Pharmacy and Life Sciences 2013; 2: 270-284.
16. Mudgal V.K, Singhai A.K, Orally Disintegrating tablet: A Review, International Research Journal of Pharmacy 2011; ISSN 2230-8407.
17. Rahul C, Zahra H, Farhan A, Alan MS, Afzal RM. The role of formulation excipients in the development of Lyophilised fast – disintegrating tablets. Eur. J. Pharm. Biopharm.2009;72:119-229.
18. Jain D, Amul M (2014) A Review – Formulation & Development of Orodispersible Tablet. Int J Pharm Eru 4: 21-38.
19. Pebley WS, Jager NE, Thompson SJ. Rapidly disintegrating tablet. US Patent 5,1994; 298, 261.
20. Deepak H, Geeta A, Hari Kumar SL. Recent trends of fast dissolving drug delivery system – An overview of formulation technology. Pharmacophore 2013;4(1):1-9.
21. Bangale GS, Yadav GJ, Shinde GV and Stephen Rathinaraj B: New Generation of Orodispersible Tablets: Recent Advances and Future Prospects. International Journal of Pharmacy and Pharmaceutical Science Research 2011; 1(2): 52-62.
22. Harsoliya MS, Pathan JK and Shruti S: A Review Formulation of Mouth Dissolving tablet.International Journal of Pharmaceutical and Clinical Science 2011; 1(1): 1-8.
23. Mishra DN, Bimodal M, Singh SK, Vijaya Kumar SG (2006) Spray dried excipient base: a novel technique for the formulation of orally disintegratinuhg tablets. Chem Pharm Bull 54(1): 99-102
24. Debit Bhowmik, B. Jayakar, K. Sampath Kumar. Fast dissolving drug delivery system; International Journal of Pharma Research 2009,1(1),31 40.
25. Rangu N, Kumari BC, Akula G, Jaswanth A. Formulation and Evaluation of Metoprolol Orodispersible Tablets by Super Disintegration Method. Asian J Pharm Res. 2018;8(3):119.
26. Mohire N, Yadav A, Gaikwad V. Novel Approaches in Development of Metronidazole Orodispersible Tablets. Res J Pharm Technol. 2009;2(2):283–6.
27. Mandlik S, Nandare D, Joshi M, Chudiwal P, Jain K. Statistical Optimization of Orodispersible Tablets Containing Telmisartan Using Factorial Design and Response Surface Methodology. Res J Pharm Technol. 2009;2(3):548–51.
28. Sanket K, Garg SK, Ajay A, Pradeep L. Fast dissolving tablets (FDTS): Recent trends and new market opportunities. Indo Am J Pharm Res 2014;4(7):3265-79.
29. Rish RK. A review on fast dissolving tablets techniques. The Pharma Review 2004; 2: 32. 64. Caramella C. Int J Pharm Techno Prod Mfr. 1984; 5:1‐5.
30. Adel M, Semreen MK, Qato KM, et al. fast dissolving dosageforms‐ technique. Pharm Tech 2005; 2: 68‐75.
31. Dobetti L. Fast‐ Melting Tablets: Developments and Technologies: Pharmaceutical Technology. Drug Delivery 2001 (Supplement): 44‐50.
32. Allen LV, Wang B, Davis JD, et al. US patent 5,1998; 807, 567. 68. Ghosh T, Ghosh A, Prasad D. A Review on New Generation Orodispersible Tablets and its future prospective. Int Journ Pharm Pharm Sci 2011.
33. Deepika J, Mishra A. A review – Formulation and development of orodispersible tablet. Int J Pharm Erudition 2014;4(1):21-38.
34. Kalpesh G, Lalit K, Kori M, Sharma C, Nema R. Formulation and characterisation of fast dissolving tablet of Aceclofenac by sublimation method. International Journal of Pharmaceutical Science and Research.2011;3:19-22